KRAS and adenocarcinoma: In the present study (mostly Asian cases), the frequency of KRAS mutations was significantly higher in HNF4α-positive adenocarcinomas (39.4%, 13/33 cases) than in HNF4α-negative adenocarcinomas (9.2%, 19/207 cases).